ContextVision AB – Mandatory notification of trade


Stockholm, February 22nd, 2016  

Karin Bernadotte, board member and primary insider in ContextVision AB, has on February 19th, 2016 purchased 3 500 shares in ContextVision AB at a price of NOK 28,00 per share. Following this transaction, Karin Bernadotte owns 6 500 shares in ContextVision AB.


“The company is in an extremely interesting phase, and I feel very confident about the ongoing research and the future for ContextVision” comments Karin Bernadotte.

 
For inquires please contact CEO Anita Tollstadius; anita.tollstadius@contextvision.se
 
This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act.


About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform.

ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.


Download pdf »